(MENAFN- Investor Brand Network)
HealthLynked (OTCQB: HLYK)
a provider of healthcare technology solutions, has appointed Jeremy Daniel as its new Chief financial Officer, effective immediately. With over 20 years of experience in healthcare, biotechnology, and finance, Daniel brings expertise in financial management, strategic planning, and organizational growth. Previously CFO at Innoveren Scientific, he has a strong track record in fundraising, mergers, and acquisitions, having raised over $100 million in funding. CEO Michael Dent, M.D., highlighted Daniel's alignment with HealthLynked's mission to innovate and expand its healthcare technology solutions. Daniel, a CPA and Xavier University MBA graduate, expressed enthusiasm for advancing the company's financial strategies and enhancing healthcare connectivity.
To view the full press release, visit
About HealthLynked Corp.
HealthLynked Corp. is committed to improving global healthcare by facilitating the efficient exchange of medical information between patients and providers. The company's network empowers members to actively manage their healthcare through a centralized and secure platform. For more information about HealthLynked Corp., please visit
.
NOTE TO INVESTORS:
The latest news and updates relating to HealthLynked are available in the company's newsroom at
About BioMedWire
BioMedWire
(“BMW”) is a specialized communications platform with a focus on the latest developments in the Biotechnology (BioTech), Biomedical Sciences (BioMed) and Life Sciences sectors. It is one of 70+ brands within the
Dynamic Brand Portfolio
@
IBN
that delivers :
(1) access to a vast network of wire solutions via
InvestorWire
to efficiently and effectively reach a myriad of target markets, demographics and diverse industries ;
(2) article and
editorial syndication to 5,000+ outlets ;
(3) enhanced
press release enhancement
to ensure maximum impact ;
(4)
social media distribution
via IBN to millions of social media followers ;
and (5) a full array of tailored
corporate communications solutions . With broad reach and a seasoned team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today's market, BMW brings its clients unparalleled recognition and brand awareness.
BMW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from BioMedWire,“Biotech” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published:
/Disclaimer
BioMedWire
Austin, Texas
512.354.7000 Office
[email protected]
BioMedWire is powered by
IBN
MENAFN15012025000224011066ID1109094679
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.